| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| COMVITA Aktie jetzt für 0€ handeln | |||||
| 17.12.25 | COMVITA LIMITED: Comvita advises results of resolutions at Annual Meeting | 1 | NZX | ||
| 17.12.25 | COMVITA LIMITED: Comvita 2025 Annual Shareholders' Meeting | 1 | NZX | ||
| 12.12.25 | Comvita edges toward capital raise to support "recapitalisation" | 2 | Just Food | ||
| 11.12.25 | COMVITA LIMITED: Comvita reaches agreement with lending partners | 1 | NZX | ||
| 20.11.25 | COMVITA LIMITED: Comvita announces key leadership appointments | 2 | NZX | ||
| 20.11.25 | COMVITA LIMITED: SPH Notice - Florenz Limited, Dame Adrienne & Mark Stewart | 1 | NZX | ||
| 18.11.25 | COMVITA LIMITED: Notice of Annual Meeting | - | NZX | ||
| 17.11.25 | COMVITA LIMITED: Comvita announces change to Board of Directors | 1 | NZX | ||
| 17.11.25 | Comvita sale to Manuka honey peer Florenz falls through | - | Just Food | ||
| 16.11.25 | COMVITA LIMITED: Scheme resolution not passed. SIA terminated. | 1 | NZX | ||
| 14.11.25 | COMVITA LIMITED: Scheme Meeting address and presentation | 1 | NZX | ||
| 12.11.25 | COMVITA LIMITED: Scheme - Update on Voting Progress Ahead of Scheme Meeting | 2 | NZX | ||
| 11.11.25 | COMVITA LIMITED: Scheme of Arrangement - Further update on Voting | 2 | NZX | ||
| 10.11.25 | COMVITA LIMITED: Scheme of Arrangement - Update on Voting | - | NZX | ||
| 09.11.25 | COMVITA LIMITED: CVT director nominations - closing date extension | 1 | NZX | ||
| 07.11.25 | COMVITA LIMITED: Scheme Update - Correction to Florenz Disclosure | 1 | NZX | ||
| 04.11.25 | COMVITA LIMITED: Performance Share Rights - Capital Change Notice | 1 | NZX | ||
| 02.11.25 | COMVITA LIMITED: Comvita Limited director nominations | 1 | NZX | ||
| 22.10.25 | COMVITA LIMITED: Comvita provides Q1 FY26 Trading Update | 1 | NZX | ||
| 21.10.25 | COMVITA LIMITED: CVT Acknowledgement of Corrective Statement from A Bougen | - | NZX |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PAVMED | 11,970 | 0,00 % | PAVmed-subsidiary Lucid Diagnostics spikes on Veterans Affairs contract | ||
| SIEMENS HEALTHINEERS | 43,630 | -2,00 % | ANALYSE-FLASH: UBS hebt Ziel für Siemens Healthineers auf 51 Euro - 'Neutral' | ZÜRICH (dpa-AFX Broker) - Die Schweizer Großbank UBS hat das Kursziel für Siemens Healthineers von 50 auf 51 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Die Aktien der Bayern seien... ► Artikel lesen | |
| FRESENIUS | 47,640 | +1,10 % | ROUNDUP/Aktien Frankfurt Schluss: Kleines Dax-Plus - Chip-Ausrüster gesucht | FRANKFURT (dpa-AFX) - Optimistische Wachstumsprognosen des taiwanesischen Chip-Giganten TSMC haben den Aktien deutscher Zulieferer für die Chip-Industrie am Donnerstag kräftig Aufwind verliehen. Ansonsten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,630 | +1,81 % | AKTIE IM FOKUS: FMC schließen sich Davita-Schwäche an - Grippesaison in USA | FRANKFURT (dpa-AFX Broker) - Die Aktien von FMC sind am Mittwoch unter 37 Euro und damit auf das tiefste Niveau seit Herbst 2024 gefallen. Dabei verloren die Papiere des Dialysekonzerns 6 Prozent.... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 35,200 | -0,73 % | Goldman setzt den Rotstift an: Carl Zeiss Meditec im Kurskeller: Analysten senken Kursziel drastisch | © Foto: Foto: ZEISSGoldman Sachs senkt das Kursziel für Carl Zeiss Meditec von 54 auf 42 Euro und stuft die Aktie auf "Neutral" herab. Ein schwaches erstes Quartal und strukturelle Probleme belasten... ► Artikel lesen | |
| HEARTFLOW | 33,550 | -1,87 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 6,060 | 0,00 % | Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic | MINNEAPOLIS and BRISBANE, Australia, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ: AVR, ASX: AVR), a global structural heart company committed... ► Artikel lesen | |
| GENEDX | 100,04 | +0,36 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| PROGYNY | 25,450 | +0,28 % | Forecasting The Future: 6 Analyst Projections For Progyny | ||
| PRIVIA HEALTH GROUP | 23,600 | +1,68 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2025 Financial Results | Very Strong Third Quarter and Year-to-Date Performance Across the BusinessNet Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q'24Implemented Providers +13.1% and Practice Collections +27.1%... ► Artikel lesen | |
| RXSIGHT | 9,950 | 0,00 % | Expert Outlook: RxSight Through The Eyes Of 5 Analysts | ||
| BRIGHTSPRING HEALTH SERVICES | 39,210 | +1,24 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,300 | 0,00 % | Alignment Healthcare Named to the 2026 Fortune World's Most Admired Companies List for First Time | ||
| PROCEPT BIOROBOTICS | 30,940 | +2,08 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| UNITEDHEALTH | 297,40 | -0,07 % | UNITEDHEALTH GROUP INC zeigt strukturelle Stärke |